Michael J Flais, MD | |
10733 W. 165th St., Orland Park, IL 60467-8713 | |
(708) 957-7468 | |
(708) 957-7471 |
Full Name | Michael J Flais |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 10733 W. 165th St., Orland Park, Illinois |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003899808 | NPI | - | NPPES |
036102033 | Medicaid | IL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 36102033 (Illinois) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michael J Flais, MD 10733 W. 165th St., Orland Park, IL 60467-8713 Ph: (708) 957-7468 | Michael J Flais, MD 10733 W. 165th St., Orland Park, IL 60467-8713 Ph: (708) 957-7468 |
News Archive
Merge Healthcare has combined its expertise in medical imaging and clinical trials management software to launch a complete workflow solution for imaging in clinical trials. The new CIMS solution is the first open platform in the industry that allows organizations involved in clinical trials to transparently execute the imaging portion of the study within the overall electronic trial management solution.
Cardiac allograft vasculopathy (CAV), also known as chronicle rejection, is a leading cause of graft (foreign heart) loss and death in patients who survive the first year after heart transplantation. The typical pathological change of CAV is gradually thickening of coronary wall in "foreign" heart due to continuous immunological reaction between donated heart and the host. In some cases, undetected CAV may silently cause graft failure with global myocardial ischemia without any documented infarction signs. Thus, continually monitoring development of asymptomatic CAV is important for selecting prophylactic strategies to get better prognosis. However, most current examinations of detecting CAV are invasive and with certain risks.
Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year in a randomized trial, results that suggest self-monitoring should not be routine in these patients, according to a new study published by JAMA Internal Medicine.
Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.
› Verified 8 days ago
Dr. Padma Tipirneni, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 17608 San Bernardino Dr, Orland Park, IL 60467 Phone: 650-704-7523 | |
Richard R Fitzsimons, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10733 W. 165th St., Orland Park, IL 60467 Phone: 708-957-7468 Fax: 708-957-7471 | |
Cassandra Adams Lickert, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 9550 W 167th St, Orland Park, IL 60467 Phone: 708-873-4500 Fax: 708-873-4505 | |
Umapathi Cattamanchi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10759 Winterset Dr, Unit A2, Orland Park, IL 60467 Phone: 708-460-8111 Fax: 708-460-8110 | |
Timothy J. Brown, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 10733 W. 165th St., Orland Park, IL 60467 Phone: 708-957-7468 Fax: 708-957-7471 | |
Mark Lowenthal, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10733 W. 165th St., Orland Park, IL 60467 Phone: 708-957-7468 Fax: 708-957-7471 |